Charles J. Casamento - 01 Apr 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Charles J. Casamento
Issuer symbol
RLMD
Transactions as of
01 Apr 2022
Net transactions value
-$510,048
Form type
4
Filing time
05 Apr 2022, 17:00:12 UTC
Previous filing
28 Feb 2022
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Options Exercise $64,152 +19,800 $3.24 19,800 01 Apr 2022 Direct
transaction RLMD Common Stock Sale $95,700 -3,300 -17% $29.00 16,500 01 Apr 2022 Direct F1
transaction RLMD Common Stock Sale $95,700 -3,300 -20% $29.00 13,200 01 Apr 2022 Direct F1
transaction RLMD Common Stock Sale $95,700 -3,300 -25% $29.00 9,900 01 Apr 2022 Direct F1
transaction RLMD Common Stock Sale $95,700 -3,300 -33% $29.00 6,600 01 Apr 2022 Direct F1
transaction RLMD Common Stock Sale $95,700 -3,300 -50% $29.00 3,300 01 Apr 2022 Direct F1
transaction RLMD Common Stock Sale $95,700 -3,300 -100% $29.00 0 01 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Options Exercise $0 +19,800 +34% $0.000000 77,511 01 Apr 2022 Common Stock 19,800 $3.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
F2 The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period..